| Product Code: ETC12465506 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Poland Immunotherapy Drugs Market Overview |
3.1 Poland Country Macro Economic Indicators |
3.2 Poland Immunotherapy Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Poland Immunotherapy Drugs Market - Industry Life Cycle |
3.4 Poland Immunotherapy Drugs Market - Porter's Five Forces |
3.5 Poland Immunotherapy Drugs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Poland Immunotherapy Drugs Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 Poland Immunotherapy Drugs Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Poland Immunotherapy Drugs Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.9 Poland Immunotherapy Drugs Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
4 Poland Immunotherapy Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Poland |
4.2.2 Growing awareness about the benefits of immunotherapy |
4.2.3 Rising healthcare expenditure in the country |
4.3 Market Restraints |
4.3.1 High cost associated with immunotherapy drugs |
4.3.2 Stringent regulatory requirements for drug approval in Poland |
5 Poland Immunotherapy Drugs Market Trends |
6 Poland Immunotherapy Drugs Market, By Types |
6.1 Poland Immunotherapy Drugs Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Poland Immunotherapy Drugs Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Poland Immunotherapy Drugs Market Revenues & Volume, By Checkpoint Inhibitors, 2021 - 2031F |
6.1.4 Poland Immunotherapy Drugs Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.1.5 Poland Immunotherapy Drugs Market Revenues & Volume, By Cancer Vaccines, 2021 - 2031F |
6.1.6 Poland Immunotherapy Drugs Market Revenues & Volume, By Cytokines, 2021 - 2031F |
6.1.7 Poland Immunotherapy Drugs Market Revenues & Volume, By Adoptive T-Cell Therapy, 2021 - 2031F |
6.2 Poland Immunotherapy Drugs Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 Poland Immunotherapy Drugs Market Revenues & Volume, By Lung Cancer, 2021 - 2031F |
6.2.3 Poland Immunotherapy Drugs Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.2.4 Poland Immunotherapy Drugs Market Revenues & Volume, By Melanoma, 2021 - 2031F |
6.2.5 Poland Immunotherapy Drugs Market Revenues & Volume, By Leukemia, 2021 - 2031F |
6.2.6 Poland Immunotherapy Drugs Market Revenues & Volume, By Multiple Myeloma, 2021 - 2031F |
6.3 Poland Immunotherapy Drugs Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Poland Immunotherapy Drugs Market Revenues & Volume, By Oncology Centers, 2021 - 2031F |
6.3.3 Poland Immunotherapy Drugs Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.4 Poland Immunotherapy Drugs Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.5 Poland Immunotherapy Drugs Market Revenues & Volume, By Research Institutions, 2021 - 2031F |
6.3.6 Poland Immunotherapy Drugs Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.4 Poland Immunotherapy Drugs Market, By Mechanism of Action |
6.4.1 Overview and Analysis |
6.4.2 Poland Immunotherapy Drugs Market Revenues & Volume, By PD-1/PD-L1 Blocking, 2021 - 2031F |
6.4.3 Poland Immunotherapy Drugs Market Revenues & Volume, By Immune System Activation, 2021 - 2031F |
6.4.4 Poland Immunotherapy Drugs Market Revenues & Volume, By Tumor Cell Recognition, 2021 - 2031F |
6.4.5 Poland Immunotherapy Drugs Market Revenues & Volume, By Signal Pathway Modulation, 2021 - 2031F |
6.4.6 Poland Immunotherapy Drugs Market Revenues & Volume, By CAR-T Cell Therapy, 2021 - 2031F |
6.5 Poland Immunotherapy Drugs Market, By Sales Channel |
6.5.1 Overview and Analysis |
6.5.2 Poland Immunotherapy Drugs Market Revenues & Volume, By Direct Sales, 2021 - 2031F |
6.5.3 Poland Immunotherapy Drugs Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.5.4 Poland Immunotherapy Drugs Market Revenues & Volume, By Wholesale Suppliers, 2021 - 2031F |
6.5.5 Poland Immunotherapy Drugs Market Revenues & Volume, By Government Procurement, 2021 - 2031F |
6.5.6 Poland Immunotherapy Drugs Market Revenues & Volume, By Hospital Contracts, 2021 - 2031F |
7 Poland Immunotherapy Drugs Market Import-Export Trade Statistics |
7.1 Poland Immunotherapy Drugs Market Export to Major Countries |
7.2 Poland Immunotherapy Drugs Market Imports from Major Countries |
8 Poland Immunotherapy Drugs Market Key Performance Indicators |
8.1 Patient survival rates post immunotherapy treatment |
8.2 Rate of adoption of immunotherapy drugs by healthcare facilities |
8.3 Number of clinical trials for immunotherapy drugs in Poland |
9 Poland Immunotherapy Drugs Market - Opportunity Assessment |
9.1 Poland Immunotherapy Drugs Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Poland Immunotherapy Drugs Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 Poland Immunotherapy Drugs Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Poland Immunotherapy Drugs Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.5 Poland Immunotherapy Drugs Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
10 Poland Immunotherapy Drugs Market - Competitive Landscape |
10.1 Poland Immunotherapy Drugs Market Revenue Share, By Companies, 2024 |
10.2 Poland Immunotherapy Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here